Roche Diagnostics, of Basel, Switzerland, formed a collaboration with Indianapolis-based Eli Lilly and Co., in which they will work with Response Genetics Inc., of Los Angeles, to confirm biomarkers that may be used to identify patients most likely to respond to certain cancer therapies.(Other News To Note)

Roche Diagnostics, of Basel, Switzerland, formed a collaboration with Indianapolis-based Eli Lilly and Co., in which they will work with Response Genetics Inc., of Los Angeles, to confirm biomarkers that may be used to identify patients most likely to respond to …